ExCell Bio Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $881K

  • Investors
  • 12

ExCell Bio General Information

Description

Supplier of biological reagents and consumables for the upstream tool industry of biomedicine. The company provides raw materials and technical services for customers in the fields of biopharmaceuticals, precision medicine and so on, its products include serum-free culture medium, foetal bovine serum and functional identification kits, committing to accelerating the application of life science and technology and continuously improving human health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 18
  • No. 481, Guiping Road, Xuhui District
  • Shanghai, 200233
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Medical Supplies
Vertical(s)
Corporate Office
  • 5th Floor, Building 18
  • No. 481, Guiping Road, Xuhui District
  • Shanghai, 200233
  • China
+86 021

ExCell Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExCell Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Debt - General 27-Jun-2023 $881K Completed
6. Later Stage VC (Series B2) 09-May-2023 Completed Generating Revenue
5. Later Stage VC (Series B1) 07-Jan-2023 Completed Generating Revenue
4. Later Stage VC (Series B) 22-Oct-2021 Completed Generating Revenue
3. Later Stage VC 12-Oct-2020 Completed Generating Revenue
2. Later Stage VC 01-Aug-2020 Completed Generating Revenue
1. Early Stage VC (Series A) 02-Dec-2016 Completed Generating Revenue
To view ExCell Bio’s complete valuation and funding history, request access »

ExCell Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABCI Securities Investment Bank Minority
GP Capital (Shanghai) PE/Buyout Minority
Shenzhen Investment Holdings Asset Manager Minority
Haiwang Capital Venture Capital Minority
CICC Private Equity Corporate Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

ExCell Bio FAQs

  • When was ExCell Bio founded?

    ExCell Bio was founded in 2013.

  • Where is ExCell Bio headquartered?

    ExCell Bio is headquartered in Shanghai, China.

  • What industry is ExCell Bio in?

    ExCell Bio’s primary industry is Biotechnology.

  • Is ExCell Bio a private or public company?

    ExCell Bio is a Private company.

  • What is ExCell Bio’s current revenue?

    The current revenue for ExCell Bio is .

  • How much funding has ExCell Bio raised over time?

    ExCell Bio has raised $60M.

  • Who are ExCell Bio’s investors?

    ABCI Securities, GP Capital (Shanghai), Shenzhen Investment Holdings, Haiwang Capital, and CICC Private Equity are 5 of 12 investors who have invested in ExCell Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process